CTMX Cytomx Therapeutics Inc

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.

$7.60  -0.62 (-7.49%)
As of 03/04/2021 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
10/08/2015
46,224,402
871,758
$379,502,340
0.00%
SEC Edgar Online
10-Q
10-K
23284F105
US23284F1057
BYWVTY5

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-11.54
7.96
3.78
-66.03%
-32.77%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy